Skip to content
healthcare.dev
Get a free key

Ledipasvir and Sofosbuvir

NDC 72626-2601, Ledipasvir and Sofosbuvir, tablet, film coated, from Asegua Therapeutics LLC.

Product NDC
72626-2601
Status
Listed
Labeler
Asegua Therapeutics LLC
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA205834
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72626-2601 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LEDIPASVIR90 mg/1
  • SOFOSBUVIR400 mg/1

Pharmacologic classes

Breast Cancer Resistance Protein Inhibitors [MoA]; Hepatitis C Virus NS5A Inhibitor [EPC]; Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]; P-Glycoprotein Inhibitors [MoA]; RNA Replicase Inhibitors [MoA]

Package NDCNDC-11Package
72626-2601-1726262601012 BLISTER PACK in 1 CARTON (72626-2601-1) / 14 TABLET, FILM COATED in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/46f4a73b-0cd6-4902-9092-3ac79e882c1a

Use it

Look up 72626-2601 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72626-2601 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72626-2601. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.